EQUINOK
Retrospective Observational Study - Evaluation of Quality Indicators in Patients Receiving Intensive Care and Their Influence on Outcome Indicators and Economic Indicators
Sponsor study identifier
observational
35,000
1 country
1
Study Start
March 5, 2026
Actual (reported)Primary Completion
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The aim of the study is to identify and evaluate incentive mechanisms for the implementation of quality-relevant care processes. The objective is to correlate adherence to individual process-based quality indicators or their combination with outcome data. In addition, cost shares and case revenues are evaluated. Indices are also derived from routine data that may represent additional influencing factors (Charlson Comorbidity Index or secondary diagnoses that increase case severity based on ICD-10 coding and procedures based on the Surgery and procedure codes system).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 22, 2026
Actual (reported)March 5, 2026
Actual (reported)March 30, 2026
Actual (reported)December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Proceeds
Per Case Revenue in Euro \[€\] (Revenue = base rate x DRG-rate) according to the Diagnosis Related Groups (DRG) reimbursement flat rate catalogue and the base rate for the state of Berlin for the respective billing year.
2012-2024
Case costs
Per case costs in Euro \[€\] according to case-related analysis based on financial controlling data.
2012-2024
Charlson Comorbidity Index
2012-2024
30-day readmission rate
2012-2024
In-house mortality
2012-2024
Infection rate
2012-2024
Length of hospital stay (days)
2012-2024
Degrees of fulfillment of process-based quality indicators
2012-2024
Quality indicator compliance
2012-2024
Outcome indicators
2012-2024
Intensive care unit patients (2012-2022) from the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) of Charité - University Medicine Berlin with a length of stay \> 24 hours.
Department of Anaesthesiolgy and Intensive Care Medicine (CCM/CVK), Charite- University Berlin
Berlin, 10117, Germany
Claudia Spies, MD, Prof.
Charite University, Berlin, Germany
First Submitted
January 22, 2026
First Posted
March 30, 2026
Study Start
March 5, 2026
Actual (reported)Primary Completion
December 31, 2028
EstimatedContact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 19, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: